The rapid approval by the Russian health ministry of a vaccine against COVID-19 based on limited human data has provoked disquiet among experts, as confusion reigns over the country’s exact plans for Phase III studies and its mass vaccination program.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?